Confronto
Buserelin vs. Melanotan II
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
57982-77-1
121062-08-6
Peso molecolare
1239.42 g/mol
1024.18 g/mol
Emivita
nessun dato
1 h
Sequenza
nessun dato
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2Meccanismo d'azione
Buserelin
Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.
Melanotan II
Melanotan II binds non-selectively to all five melanocortin-receptor subtypes (MC1R-MC5R). Via MC1R in melanocytes, eumelanin synthesis is stimulated (pigmenting effect). Via MC4R and MC3R in the CNS, appetite, sexual function and blood pressure are modulated. The cyclic structure and D-amino acids increase stability compared to natural α-MSH.
Base di evidenze
Evidenza più alta
RCT sull'uomo
Studio sull'uomo
Studi
0
9
di cui sull'uomo
0
5
Effetti registrati
2
4
Contraddizioni aperte
0
1
Eventi avversi documentati
1
6
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Buserelin and Melanotan II?
- Buserelin is classified as "Ricerca (altro)", while Melanotan II is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Melanotan II: Cyclic hepta-peptide and non-selective melanocortin-receptor agonist. Originally researched at the University of Arizona as a sun-protection concept — never approved as a medicine. Widespread on the black market; regulatory warnings for cardiovascular and oncological risks. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Buserelin or Melanotan II?
- The highest available evidence level is "RCT sull'uomo" for Buserelin and "Studio sull'uomo" for Melanotan II. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Buserelin and Melanotan II in Germany and the United States?
- Germania: Buserelin — Su prescrizione, Melanotan II — Non approvato. Stati Uniti: Buserelin — Non approvato, Melanotan II — Non approvato. These are factual summaries with source and review date on the individual pages.